Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J Rare Dis. 2014;9:98.<\/p>\n
Article<\/a>\u00a0 Health, AIo. Welfare. Chronic kidney disease: Australian facts. Canberra: AIHW; 2024.<\/p>\n Health, AIo. Welfare. Heart, stroke and vascular disease: Australian facts. Canberra: AIHW; 2024.<\/p>\n Irish G, Au CDE, Bateman S, Chen J, Hurst K, Kholmurodova F, Lee D, McCarthy H, McDonald, S, Mulley W, Solomon MRB, Sun T. P Clayton. Chapter 1: Incidence of kidney failure with replacement therapy. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA, 2024. Available at: http:\/\/www.anzdata.org.au<\/a>.<\/p>\n Cornec-Le Gall E, Audr\u00e9zet M-P, Renaudineau E, Hourmant M, Charasse C, Michez E, et al. PKD2-Related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation spectrum, and prognosis. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2017;70(4):476\u201385.<\/p>\n Article<\/a>\u00a0 Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41(5):1311\u20139.<\/p>\n Article<\/a>\u00a0 Johnson AM, Gabow PA. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol. 1997;8(10):1560\u20137.<\/p>\n Article<\/a>\u00a0 Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: A population and Family-Based cohort followed for 22 years. Clin J Am Soc Nephrol. 2006;1(4):710.<\/p>\n Article<\/a>\u00a0 Fernando MR, Dent H, McDonald SP, Rangan GK. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and new Zealand (1963\u20132014). Popul Health Metrics. 2017;15(1):7.<\/p>\n Article<\/a>\u00a0 Rahman E, Niaz FA, Al-Suwaida A, Nahrir S, Bashir M, Rahman H, Hammad D. Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl. 2009;20(5):806\u201310.<\/p>\n PubMed<\/a>\u00a0 Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol. 2009;4(10):1620\u20138.<\/p>\n Article<\/a>\u00a0 Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, et al. Identifying patient-important outcomes in polycystic kidney disease: an international nominal group technique study. Nephrol (Carlton). 2019;24(12):1214\u201324.<\/p>\n Article<\/a>\u00a0 Lee LJ-H, Tsai L-K, Chang Y-Y, Wang J-D, Kao JT-W. Incidence of stroke among patients with polycystic kidney disease in Taiwan: A retrospective population-based cohort study using National health insurance database. Biomedical J. 2021;45(5):806\u201313.<\/p>\n Yoo DJ, Agodoa L, Yuan CM, Abbott KC, Nee R. Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease. BMC Nephrol. 2014;15(1):39.<\/p>\n Article<\/a>\u00a0 Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001;38(4):777\u201384.<\/p>\n Article<\/a>\u00a0 Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2013an analysis of data from the ERA-EDTA registry. Nephrol Dial Transpl. 2014;29(Suppl 4):iv15\u201325.<\/p>\n Article<\/a>\u00a0 Mart\u00ednez V, Comas J, Arcos E, D\u00edaz JM, Muray S, Cabezuelo J, et al. Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol. 2013;14:186.<\/p>\n Article<\/a>\u00a0 Sigogne M, Kanagaratnam L, Dupont V, Couchoud C, Verger C, Maheut H, et al. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a National retrospective study based on two French registries (the French Language peritoneal Dialysis registry and the French renal epidemiology and information Network). Nephrol Dial Transpl. 2018;33(11):2020\u20136.<\/p>\n Article<\/a>\u00a0 Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, et al. Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol. 2009;4(10):1620\u20138. https:\/\/doi.org\/10.2215\/cjn.01750309<\/a>. Epub 2009\/09\/05.<\/p>\n Article<\/a>\u00a0 Fenton SSA, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30(3):334\u201342. https:\/\/doi.org\/10.1016\/S0272-6386(97)90276-6<\/a>.<\/p>\n Article<\/a>\u00a0 Lee JY, Cho H, Park JH, Jo YI. Comparison of survival outcomes in haemodialysis versus immediate-start peritoneal dialysis: A propensity-matched study. Nephrol (Carlton). 2025;30(1):e14418. https:\/\/doi.org\/10.1111\/nep.14418<\/a>. PubMed PMID: 39675379.<\/p>\n Article<\/a>\u00a0 Han HY, Vangaveti V, Jose M, Ng MSY, Mallett AJ. People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases. Sci Rep. 2024;14(1):6746.<\/p>\n Article<\/a>\u00a0 Au E, Bateman S, Chen J, Hurst K, Irish G, Lee D, et al. 46th report, Chapter 3: Mortality in kidney failure with replacement therapy. Adelaide (AU): Australia and New Zealand Dialysis and Transplant Registry; 2023.<\/p>\n Flahault A, Joly D. Screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2019;14(8):1242\u20134.<\/p>\n Article<\/a>\u00a0 Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5(12):2048\u201356.<\/p>\n Article<\/a>\u00a0 Schwab SJ, Bander SJ, Klahr S. Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987;82(4):714\u20138.<\/p>\n Article<\/a>\u00a0 Sagar PS, Rangan GK. Cardiovascular manifestations and management in ADPKD. Kidney Int Rep. 2023;8(10):1924\u201340.<\/p>\n Article<\/a>\u00a0 Patch C, Charlton J, Roderick PJ, Gulliford MC. Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis. 2011;57(6):856\u201362. https:\/\/doi.org\/10.1053\/j.ajkd.2011.01.023<\/a>. Epub 20110402.<\/p>\n Article<\/a>\u00a0 Aung TT, Bhandari SK, Chen Q, Malik FT, Willey CJ, Reynolds K et al. Autosomal dominant polycystic kidney disease prevalence among a racially diverse United States population, 2002 through 2018. Kidney360. 2021. https:\/\/doi.org\/10.34067\/KID.0004522021<\/a>.<\/p>\n St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC et al. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst Rev. 2024;10(10):Cd010294. Epub 20241002. https:\/\/doi.org\/10.1002\/14651858.CD010294.pub3<\/a>. PubMed PMID: 39356039; PubMed Central PMCID: PMC11445802.<\/p>\n Tran W-C, Huynh D, Chan T, Chesla CA, Park M. Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease. BMC Nephrol. 2017;18(1):214.<\/p>\n Article<\/a>\u00a0 Jacquet A, Pallet N, Kessler M, Hourmant M, Garrigue V, Rostaing L, et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int. 2011;24(6):582\u20137.<\/p>\n Article<\/a>\u00a0 Hadimeri H, Nord\u00e9n G, Friman S, Nyberg G. Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transpl. 1997;12(7):1431\u20136.<\/p>\n Article<\/a>\u00a0 Stiasny B, Ziebell D, Graf S, Hauser IA, Schulze BD. Clinical aspects of renal transplantation in polycystic kidney disease. Clin Nephrol. 2002;58(1):16\u201324.<\/p>\n Article<\/a>\u00a0 Bhutani G, Astor BC, Mandelbrot DA, Mankowski-Gettle L, Ziemlewicz T, Wells SA, et al. Long-Term outcomes and prognostic factors in kidney transplant recipients with polycystic kidney disease. Kidney360. 2021;2(2):312\u201324.<\/p>\n Article<\/a>\u00a0 Chedid M, Kaidbay H-D, Wigerinck S, Mkhaimer Y, Smith B, Zubidat D, et al. Cardiovascular outcomes in kidney transplant recipients with ADPKD. Kidney Int Rep. 2022;7(9):1991\u20132005.<\/p>\n Article<\/a>\u00a0 Tsai TY, Chen CH, Wu MJ, Tsai SF. Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-Years Follow-Up. Diagnostics (Basel). 2022;12(5).<\/p>\n Culliford A, Phagura N, Sharif A. Autosomal dominant polycystic kidney disease is a risk factor for posttransplantation diabetes mellitus: an updated systematic review and Meta-analysis. Transpl Direct. 2020;6(5):e553.<\/p>\n Article<\/a>\u00a0 Li Q, Li J, Yang F, Liu Y, Deng W, Liu R, et al. [Application of immunosuppressants in patients with autosomal dominant polycystic kidney disease after kidney transplantation]. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40(4):538\u201343.<\/p>\n CAS<\/a>\u00a0 Rangan GK, Alexander SI, Campbell KL, Dexter MA, Lee VW, Lopez-Vargas P, et al. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease. Nephrology. 2016;21(8):705\u201316.<\/p>\n Article<\/a>\u00a0 Rivera M, Gonzalo A, Gobernado JM, Orte L, Quereda C, Ortu\u00f1o J. Stroke in adult polycystic kidney disease. Postgrad Med J. 1992;68(803):735\u20138.<\/p>\n Article<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W. The prevalence and epidemiology of genetic…\n","protected":false},"author":2,"featured_media":177933,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[90568,49,48,20841,84387,84,2987,74032,90569,2851],"class_list":["post-177932","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-adpkd","tag-ca","tag-canada","tag-cardiovascular-disease","tag-dialysis","tag-health","tag-internal-medicine","tag-kidney-failure","tag-nephrology","tag-transplant"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/177932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=177932"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/177932\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/177933"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=177932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=177932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=177932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}